Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma
- PMID: 28842324
- PMCID: PMC5701875
- DOI: 10.1016/j.jid.2017.07.832
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma
Abstract
Associations of MC1R with BRAF mutations in melanoma have been inconsistent between studies. We sought to determine for 1,227 participants in the international population-based Genes, Environment, and Melanoma (GEM) study whether MC1R and phenotypes were associated with melanoma BRAF/NRAS subtypes. We used logistic regression adjusted by age, sex, and study design features and examined effect modifications. BRAF+ were associated with younger age, blond/light brown hair, increased nevi, and less freckling, and NRAS+ with older age relative to the wild type (BRAF-/NRAS-) melanomas (all P < 0.05). Comparing specific BRAF subtypes to the wild type, BRAF V600E was associated with younger age, blond/light brown hair, and increased nevi and V600K with increased nevi and less freckling (all P < 0.05). MC1R was positively associated with BRAF V600E cases but only among individuals with darker phototypes or darker hair (Pinteraction < 0.05) but inversely associated with BRAF V600K (Ptrend = 0.006) with no significant effect modification by phenotypes. These results support distinct etiologies for BRAF V600E, BRAF V600K, NRAS+, and wild-type melanomas. MC1R's associations with BRAF V600E cases limited to individuals with darker phenotypes indicate that MC1R genotypes specifically provide information about BRAF V600E melanoma risk in those not considered high risk based on phenotype. Our results also suggest that melanin pathways deserve further study in BRAF V600E melanomagenesis.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
No potential conflicts of interest were disclosed.
Similar articles
-
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.J Invest Dermatol. 2018 Nov;138(11):2398-2404. doi: 10.1016/j.jid.2018.04.025. Epub 2018 May 9. J Invest Dermatol. 2018. PMID: 29753029 Free PMC article.
-
Histologic and Phenotypic Factors and MC1R Status Associated with BRAF(V600E), BRAF(V600K), and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas.J Invest Dermatol. 2016 Apr;136(4):829-837. doi: 10.1016/j.jid.2015.12.035. Epub 2016 Jan 22. J Invest Dermatol. 2016. PMID: 26807515
-
NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.J Invest Dermatol. 2013 Apr;133(4):1027-33. doi: 10.1038/jid.2012.385. Epub 2012 Oct 25. J Invest Dermatol. 2013. PMID: 23096702
-
Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta-analysis.Mol Carcinog. 2021 Mar;60(3):167-171. doi: 10.1002/mc.23280. Epub 2021 Jan 14. Mol Carcinog. 2021. PMID: 33444485 Review.
-
Functional interplay between secreted ligands and receptors in melanoma.Semin Cell Dev Biol. 2018 Jun;78:73-84. doi: 10.1016/j.semcdb.2017.06.021. Epub 2017 Jul 1. Semin Cell Dev Biol. 2018. PMID: 28676423 Review.
Cited by
-
Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.J Invest Dermatol. 2018 Nov;138(11):2398-2404. doi: 10.1016/j.jid.2018.04.025. Epub 2018 May 9. J Invest Dermatol. 2018. PMID: 29753029 Free PMC article.
-
Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management.J Clin Med. 2021 Aug 23;10(16):3760. doi: 10.3390/jcm10163760. J Clin Med. 2021. PMID: 34442055 Free PMC article. Review.
-
Ca2+ as a therapeutic target in cancer.Adv Cancer Res. 2020;148:233-317. doi: 10.1016/bs.acr.2020.05.003. Epub 2020 Jul 9. Adv Cancer Res. 2020. PMID: 32723565 Free PMC article. Review.
-
Germline Variants Impact Somatic Events during Tumorigenesis.Trends Genet. 2019 Jul;35(7):515-526. doi: 10.1016/j.tig.2019.04.005. Epub 2019 May 22. Trends Genet. 2019. PMID: 31128889 Free PMC article. Review.
References
-
- Autier P, Boniol M, Severi G, Giles G, Cattaruzza MS, Luther H, et al. The body site distribution of melanocytic naevi in 6–7 year old European children. Melanoma Res. 2001;11(2):123–31. - PubMed
-
- Bauer J, Buttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, et al. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 2011;24(2):345–51. - PMC - PubMed
-
- Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004;15(9):957–65. - PubMed
-
- Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol. 2006;35(3):756–64. - PubMed
-
- Bucheit AD, Syklawer E, Jakob JA, Bassett RL, Jr, Curry JL, Gershenwald JE, et al. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer. 2013;119(21):3821–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous